Image
main content start
Non-Insulin Treatment
Injectable Medications
In addition to insulin, numerous other medications are available to help manage diabetes. Many of the non-insulin agents are only approved for use in type 2 diabetes but to know what medication is best for you, you'll need to make that decision with your diabetes care team.
Explore All Injectable Medications
Injectable Medications category
Showing 8 of 8 Results
Injectable Medications
Bydureon BCise (exenatide extended release)
AstraZeneca
Bydureon BCise (exenatide extended-release) is a once-weekly injectable GLP-1 receptor agonist approved to treat type 2 diabetes in people 10 years and older.
Bydureon BCise (exenatide extended-release) is a once-weekly injectable GLP-1 receptor agonist approved to treat type 2 diabetes in people 10 years and older.
Compare
Injectable Medications
Mounjaro
Eli Lilly and Co.
Once-weekly injectable that mimics GLP-1 and GIP hormones to lower blood glucose and promote weight loss. Approved for adults and children 10+ with type 2 diabetes.
Once-weekly injectable that mimics GLP-1 and GIP hormones to lower blood glucose and promote weight loss. Approved for adults and children 10+ with type 2 diabetes.
Compare
Injectable Medications
Ozempic
Novo Nordisk
Once-weekly injectable GLP-1 receptor agonist that improves blood glucose and reduces heart and kidney risks. Approved for adults with type 2 diabetes.
Once-weekly injectable GLP-1 receptor agonist that improves blood glucose and reduces heart and kidney risks. Approved for adults with type 2 diabetes.
Compare
Injectable Medications
Soliqua 100/33
Sanofi
Once-daily injection that combines long-acting insulin with a GLP-1 receptor agonist for improving blood glucose. Approved for adults with type 2 diabetes.
Once-daily injection that combines long-acting insulin with a GLP-1 receptor agonist for improving blood glucose. Approved for adults with type 2 diabetes.
Compare
Injectable Medications
Trulicity
Eli Lilly and Co.
Once-weekly injectable GLP-1 receptor agonist for improving blood glucose and reducing heart risks. Approved for adults and children age 10+ with type 2 diabetes.
Once-weekly injectable GLP-1 receptor agonist for improving blood glucose and reducing heart risks. Approved for adults and children age 10+ with type 2 diabetes.
Compare
Injectable Medications
Tzield
Sanofi
Monoclonal antibody to delay stage 3 type 1 diabetes in stage 2 patients. Given by IV for 14 days. Approved for adults and children 8+ with stage 2 type 1 diabetes.
Monoclonal antibody to delay stage 3 type 1 diabetes in stage 2 patients. Given by IV for 14 days. Approved for adults and children 8+ with stage 2 type 1 diabetes.
Compare
Injectable Medications
Victoza
Novo Nordisk
Once-daily injectable GLP-1 receptor agonist for improving blood glucose and reducing heart risks. Approved for adults and children age 10+ with type 2 diabetes.
Once-daily injectable GLP-1 receptor agonist for improving blood glucose and reducing heart risks. Approved for adults and children age 10+ with type 2 diabetes.
Compare
Injectable Medications
Xultophy 100/3.6
Novo Nordisk
Once-daily injection that combines an ultra-long-acting insulin with a GLP-1 receptor agonist to improve blood glucose control. Approved for adults with type 2 diabetes.
Once-daily injection that combines an ultra-long-acting insulin with a GLP-1 receptor agonist to improve blood glucose control. Approved for adults with type 2 diabetes.
Compare
Compare (0/5)
Add products to compare and find which best fits your needs.
Add up to 5 items
Add up to 5 items
Add up to 5 items
Add up to 5 items
Other Devices & Supplies
Looking for a different way to manage diabetes care? Browse and compare information on the latest devices, tools, and technology.
